Aller au contenu principal
Institution scientifique

Zhebei Mingzhou Hospital

Huzhou, healthcare

25Publications signalées
379Citations signalées
12Thèmes principaux

Les principaux domaines

Lung Cancer Treatments and MutationsImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchAdvanced Radiotherapy TechniquesMedical Imaging Techniques and ApplicationsCancer Genomics and DiagnosticsCNS Lymphoma Diagnosis and TreatmentMachine Learning in BioinformaticsRadiomics and Machine Learning in Medical Imaging

L’évolution annuelle

2018 3
2019 4
2020 4
2021 5
2022 5
2023 2
2024 2

Les publications récentes

Accès ouvert 2024 article OpenAlex

Application effect of 18F-FDG PET/CT technique in diagnosis and prognosis evaluation of lymphoma

Chao Huang, H. Hu, Xuesheng Zheng

The objective of the study was to research diagnostic and prognostic values of 18F fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in patients with diffuse large B-cell lymphoma (DLBCL). The diagnostic sensitivity (Sen) of PET/CT (94.75 %) was remarkably higher than …

cn, jp (code pays fourni par la source)

3 citations SLAS TECHNOLOGY
Accès ouvert 2024 article OpenAlex

Diagnostic and prognostic value of independent and combined detection of computed tomography, ultrasound, and positron emission tomography - computed tomography in lymphoma

Lihong Shi, H. Hu

Lymphoma is a malignant tumor originating from the lymphopoietic system, which can affect all tissues and organs of the body. Lymphoma is highly heterogeneous and the therapeutic effect varies greatly. Different pathological types and stages of lymphoma differ greatly in terms of …

cn (code pays fourni par la source)

2 citations SLAS TECHNOLOGY
2023 article OpenAlex

The Causal Effects of Cholelithiasis on Acute Pancreatitis and Pancreatic Cancer: A Large Sample Size Mendelian Randomization Analysis

M. Sambasiva Rao, Xiaoshun Ai, Zijian Huang

BACKGROUND: The aim of two-sample Mendelian randomization (MR) with a large sample size was to explore the causal cholelithiasis impact on acute pancreatitis and pancreatic cancer. METHODS: We performed the two-sample MR analysis with two models. Publicly available summary- level information for …

cn (code pays fourni par la source)

2 citations Recent Patents on Anti-Cancer Drug Discovery
Accès ouvert 2023 article OpenAlex

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

C. Xu, Yongchang Zhang, Wenxian Wang, Qian Wang et autres

Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete …

cn, Éthiopie, hk (code pays fourni par la source)

29 citations Thoracic Cancer
Accès ouvert 2022 article OpenAlex

Chinese expert consensus on the diagnosis and treatment of HER2 ‐altered non–small cell lung cancer

Shirong Zhang, Wenxian Wang, C. Xu, Yongchang Zhang et autres

Human epidermal growth factor receptor 2 (HER2) possesses tyrosine kinase activity and participates in cell growth, differentiation and migration, and survival. Its alterations, mainly including mutations, amplifications, and overexpression are associated with poor prognosis and are one of the major drivers in …

cn, us, hk (code pays fourni par la source)

17 citations Thoracic Cancer
Accès ouvert 2022 article OpenAlex

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor

Wenxian Wang, Qian Wang, C. Xu, Ziming Li et autres

Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment. With the widespread use of ICIs in clinical practice, the increasing checkpoint inhibitor pneumonia (CIP) will be a challenge to …

cn, hk, fr (code pays fourni par la source)

20 citations Thoracic Cancer
Accès ouvert 2022 article OpenAlex

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China

C. Xu, Lu Si, Wenxian Wang, Ziming Li et autres

Gene fusions can drive tumor development for multiple types of cancer. Currently, many drugs targeting gene fusions are being approved for clinical application. At present, tyrosine receptor kinase (TRK) inhibitors targeting neurotrophic tyrosine receptor kinase (NTRK) gene fusions are among the first …

cn, Éthiopie, us, hk (code pays fourni par la source)

18 citations Thoracic Cancer
Accès ouvert 2022 article OpenAlex

Developing a Diagnostic Model to Predict the Risk of Asthma Based on Ten Macrophage‐Related Gene Signatures

Xiaoshun Ai, Hong Shen, Wang Yangyanqiu, Zhuang Jing et autres

Objective. Asthma (AS) is a chronic inflammatory disease of the airway, and macrophages contribute to AS remodeling. Our study aims at screening macrophage‐related gene signatures to build a risk prediction model and explore its predictive abilities in AS diagnosis. Methods. Three microarray …

cn (code pays fourni par la source)

13 citations BioMed Research International
Accès ouvert 2021 article OpenAlex

Secondary myelodysplastic syndromes identified via next-generation sequencing in a non-small cell lung cancer patient

Yongzhi Feng, Xialin Chen, Keran Jiang, Ding Zhang et autres

BACKGROUND: Myelodysplastic syndrome (MDS) is a group of clonal disorders characterized by ineffective and dysplastic hematopoiesis in the bone marrow with a high risk of progression to leukemia. Many studies have demonstrated that chemo-radiotherapy for cancer patients and exposure to certain chemicals …

cn, us (code pays fourni par la source)

2 citations BMC Medical Genomics
2021 conference-abstract OpenAlex

Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing—A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).

Wen xian Wang, C. Xu, Ziming Li, Zhengbo Song et autres

e21036 Background: Lung cancer with drug receptor protein kinase fusion is regarded as a large class of molecular event, which is called fusion-dependent lung cancer. Fusion-dependent lung cancer accounts for about 10%-15% of non-small cell lung cancer. Therefore, the identification and detection …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.